메디트

비상장계속사업자

MEDIT CORP

이수복

Investment Review Report

Auto-filled from disclosures & public data + AI-drafted analysis. Edit, then export to PDF/DOCX.

Editor

1.Deal Terms

2.Valuation / Exit Assumptions

Exit Scenarios100M KRW

3.Fund Eligibility

Fund mandate eligibility — no data, enter manually

Enter fund mandate requirements and applicability (Y/N) to include a table in the report.

4.Capital Changes

Not in DART — enter capital-raise history manually

Enter capital changes such as founding capital and paid-in increases.

5.Stock Options

Enter manually

Enter stock option grant history.

6.Investment Highlights

AI draft — editable

Click 'Generate AI draft' to populate data-grounded investment highlights.

7.Investment Risks

AI draft — editable

Risks are populated after 'Generate AI draft'.

8.Market Analysis

AI draft — editable

9.Business Analysis

AI draft — editable

10.Conclusion (Investment Opinion)

AI draft — editable

11.P&L Projection

Analyst estimates, manual entry (100M KRW). Generates a trend chart & table.

Enter projected revenue / op. profit / net income (100M KRW) by year to add a trend chart and table.
Preview— the document below is saved as PDF/DOCX

Investment Review Report

메디트

Business Reg. No. 1148197458 · CEO 이수복

I.Investment Overview

Target메디트 (1148197458)
Investment
Post-deal stake
ValuationPre — / Post —

II.Investment Highlights

No investment highlights written yet.

III.Investment Risks

No risks written yet.

IV.Company Profile

회사명메디트
영문명MEDIT CORP
대표자이수복
사업자등록번호1148197458
법인등록번호1101111932626
설립일2000.04.15

V.Financial Summary

Per DART disclosure · in 억/만원 (KRW)

Financial trend (100M KRW)

매출액100M KRW1,905.920212,713.920221,26120231,34620241,239.92025
영업이익100M KRW1,040.320211,432.32022-331.2202397.22024117.22025
Item20252024202320222021
자산총계1,619.6억원2,057.4억원2,730.1억원3,199억원1,928.3억원
부채총계380.9억원632.8억원275.9억원492.6억원426억원
자본총계1,238.7억원1,424.6억원2,454.2억원2,706.3억원1,502.3억원
매출액1,239.9억원1,346억원1,261억원2,713.9억원1,905.9억원
영업이익117.2억원97.2억원-331.2억원1,432.3억원1,040.3억원
순이익

VI.Financial Ratios

FY2025 basis

9.46%

영업이익률

순이익률

ROA

ROE

30.75%

부채비율

76.48%

자기자본비율

VII.R&D Activity

Fields 기계 > 산업/일반기계 · 전기/전자 > 계측기기

Keywords 3D 스캐너, 실시간 스캐닝, 소형화, 모듈화, 오픈 API

YearProjectsPapersPatents
2023001
2022001
2021003
2020004
2019104
2018103
2017200
2011000
2010100

VIII.Valuation & Exit Plan

Exit valuation
Holding period5y
Enter exit assumptions (investment, stake, exit valuation, period) to see MOIC·IRR.

This report compiles disclosure & public data and AI-drafts some sections as a research aid. It is not investment advice; the user bears final responsibility for facts and investment decisions.

메디트 투심보고서 | Alpha Lenz